Research suggests that endocrine disruptors may play a role in promoting hepatocellular carcinoma by reprogramming hepatic metabolic and immune gene networks. The relationship between metabolic and immune systems and their impact on cancer development is a complex one, involving multiple pathways and networks. Studies are exploring various aspects of this relationship, including the roles of gene regulatory networks, cellular reprogramming, and inter-organ communication.